Application
RXFP3 Antibody (C-term) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the RXFP3 antibody detected the RXFP3 protein (arrow).| Product Name | RXFP3 Antibody (C-term) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | RXFP3; RLN3R1; SALPR; Relaxin-3 receptor 1; G protein-coupled receptor SALPR; G-protein coupled receptor GPCR135; Relaxin family peptide receptor 3; Somatostatin- and angiotensin-like peptide receptor |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | RLN3R1 SALPR |
|---|---|
| Alternative Names | RXFP3 RLN3R1 SALPR Relaxin-3 receptor 1 G protein-coupled receptor SALPR G-protein coupled receptor GPCR135 Relaxin family peptide receptor 3 Somatostatin- and angiotensin-like peptide receptor |
| Molecular Weight(MW) | 51124 Da |
| Function | Receptor for RNL3/relaxin-3. Binding of the ligand inhibit cAMP accumulation |
| Tissue Specificity | Expressed predominantly in brain regions. Highest expression in substantia nigra and pituitary, followed by hippocampus, spinal cord, amygdala, caudate nucleus and corpus callosum, quite low level in cerebellum. In peripheral tissues, relatively high levels in adrenal glands, low levels in pancreas, salivary gland, placenta, mammary gland and testis |
| Cellular Localization | Cell membrane; Multi-pass membrane protein. |
| Entrez Gene | 51289 |
|---|---|
| Nucleotide Accession | NP_057652.1 |
Application
RXFP3 Antibody (C-term) western blot analysis in NCI-H292 cell line lysates (35ug/lane).This demonstrates the RXFP3 antibody detected the RXFP3 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
